CIZAR First Calming Serum

Manufacturer
Tissuegene,inc | Cosmax, Inc.
Effective date
2018-12-17
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:57:42

Label at a glance#

ProductCIZAR First Calming Serum
Active ingredientNiacinamide, Adenosine
Label structure8 sections

Indications and uses

Uses: Apply sparingly and spread evenly onto entire face after your regular toner or serum.

Dosage and administration

Directions: Take an adequate amount of this product everyday.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active ingredients: Niacinamide 2.0%, Adenosine 0.04%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive ingredients: Water, Glycerin, Butylene Glycol, Alcohol Denat., PEG-150, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Linum Usitatissimum (Linseed) Seed Extract, Lavandula Angustifolia (Lavender) Oil, Rosmarinus Officinalis (Rosemary) Leaf Oil, Moringa Oleifera Seed Oil, Calophyllum Inophyllum Seed Oil, Pentylene Glycol, Citric Acid, Arginine, PEG-60 Hydrogenated Castor Oil, Octyldodeceth-16, Panthenol, Glyceryl Acrylate/Acrylic Acid Copolymer, Diphenyl Dimethicone, Triethylhexanoin, Sodium Citrate, 1,2-Hexanediol, Polyglyceryl-10 Oleate, Hydrogenated Lecithin, Tocopherol, Phenoxyethanol, Zinc Oxide (CI 77947)

PURPOSE

OTC - PURPOSE SECTION

Purpose: Moisturizing

WARNINGS

WARNINGS SECTION

Warnings:

For external use only When using this product do not get into eyes, Stop use and ask a doctor if rash occurs Do not use on - deep puncture wounds - animal bites - serious burns

Avoid contact with eyes. Discontinue use if signs of irritation or rashes appear. Replace the cap after use. Keep Out of Reach of Children

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Uses

INDICATIONS & USAGE SECTION

Uses: Apply sparingly and spread evenly onto entire face after your regular toner or serum.

Directions

DOSAGE & ADMINISTRATION SECTION

Directions: Take an adequate amount of this product everyday.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71128-020-022020-01-31C16284748780-19d75b9d0-c44e-f424-e053-dadaa90a57cea740fda0-1f58-4640-a818-742108922fc6

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71128-020-01CIZAR First Calming Serum30 mL in 1 BOTTLE, DROPPERLIQUID303
71128-020-02CIZAR First Calming Serum1 in 1 CARTONLIQUID13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71128-020CIZAR FIRST CALMING SERUM (NIACINAMIDE, ADENOSINE) LIQUID [TISSUEGENE,INC]3Legacy NDC, 2 package rows20181217_a740fda0-1f58-4640-a818-742108922fc6.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71128-02071128-020-01, 71128-020-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
Niacinamide25X51I8RD4ACTIB
AdenosineK72T3FS567ACTIB
Water059QF0KO0RIACT
GlycerinPDC6A3C0OXIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
7ac45eec-baf3-423d-a3bd-9941d2315aa0a740fda0-1f58-4640-a818-742108922fc62018-12-17WarningsExact identifier
spl id: 7ac45eec-baf3-423d-a3bd-9941d2315aa0
spl set id: a740fda0-1f58-4640-a818-742108922fc6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.